Opioid addiction and associated cognitive damage: Inhibition by intranasal mesenchymal stem cell secretome administration
Más información
| Fecha de publicación: | 2020 |
| Objetivos: | We hypothesize that the non-invasive intranasal administration to opioid-addict rats of secretome derived from preconditioned MSCs will (i) reduce voluntary chronic opioid intake; (ii) inhibit opioid relapse and (iii) prevent cognitive disabilities associated to chronic opioid intake. |
| Instrumento: | FONDECYT |
| Año de Inicio/Término: | 2020-2004 |
| Financiamiento/Sponsor: | CONICYT |
| Rol del Usuario: | COINVESTIGADOR(A) |
| DOI: |
1200287 |